Increased Cardiovascular Comorbidities in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukaemia Presenting with Systemic Inflammatory and Autoimmune Manifestations

In this study, we aimed to characterize patient- and disease-based differences in MDS/CMML patients with and without SIAMs and explore the impact of SIAMs on progression and survival.

Source: Seminars in Hematology - May 28, 2018 Category: Hematology Authors: B. Kipfer, T. Daikeler, S. Kuchen, M. Hallal, N. Andina, R. Allam, N. Bonadies Tags: Research Article Source Type: research